Passage Bio Inc (PASG NASDAQ) stock market data APIs
$6.6879
0.02(0.3%)
as of November 5, 2025
Try our APIs with
free plan!
Passage Bio Inc Financial Data Overview
Price chart is built with
Anychart
Passage Bio, Inc., a genetic medicines company, develops gene therapies for central nervous system diseases. It develops PBGM01, a functional GLB1 gene encoding ß-galactosidase for infantile GM1; PBFT02, a functional granulin (GRN) and gene encoding progranulin (PGRN) for the treatment of FTD caused by progranulin deficiency; and PBKR03, a functional GALC gene encoding the hydrolytic enzyme galactosylceramidase for infantile Krabbe disease. The company develops PBML04 for the treatment of metachromatic leukodystrophy; PBAL05 for the treatment of amyotrophic lateral sclerosis; and other program for huntington's disease. It has a strategic research collaboration with the Trustees of the University of Pennsylvania's Gene Therapy Program; and collaboration agreement, and a development services and clinical supply agreement with Catalent Maryland, Inc. The company was incorporated in 2017 and is based in Philadelphia, Pennsylvania.
Prev. Close
6.6879
Open
6.7116
High
7.0775
Low
6.6879
52 wk Range
5.124-26.6
Market Cap
21 297 K
P/E Ratio
0.1701
Shares Outstanding
3 179 K
EPS
-2.96
Beta
1.878
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Passage Bio Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Passage Bio Inc data using free add-ons & libraries
Get Passage Bio Inc Fundamental Data
Passage Bio Inc Fundamental data includes:
- Net Revenue:
- EBITDA: -52 485 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-07-31
- EPS/Forecast: -0.202
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Passage Bio Inc News
New
Passage Bio to Present at Guggenheim Securities 2nd Annual Healthcare Innovation Conference
PHILADELPHIA, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (NASDAQ: PASG), a clinical stage genetic medicines company focused on improving the lives of patients with neurodegenerative disease...
Passage Bio to Participate in H.C. Wainwright 27th Annual Global Investment Conference
PHILADELPHIA, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (NASDAQ: PASG), a clinical stage genetic medicines company focused on improving the lives of patients with neurodegenerative disease...
Canaccord Genuity lowers Passage Bio stock price target to $67 from $260
Investing.com - Canaccord Genuity lowered its price target on Passage Bio Inc. (NASDAQ:PASG) to $67.00 from $260.00 on Thursday, while maintaining a Buy rating on the stock. Currently trading at $6.38...
Passage Bio GAAP EPS of -$2.96 beats by $1.08
* Passage Bio press release [https://seekingalpha.com/pr/20197173-passage-bio-reports-second-quarter-2025-financial-results-and-provides-recent-business] (NASDAQ:PASG [https://seekingalpha.com/symbo...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
